SAMe 200
This product has been discontinued. Label data shown is from the last available version.
Product Information
- Brand
- Klaire Labs
- Form
- Tablet or Pill
- Servings Per Container
- 60
- UPC
- 8 28054 01021 5
- Product Type
- Non-Nutrient/Non-Botanical
- DSLD Entry Date
- 2025-04-24
Target Groups
Label Statements
Formula re: Contains
SAMe 200 200 mg Elemental SAMe S-Adenosyl L-Methionine
Formulation re: Other
60 Enteric Extended Release Tablets In Foil Blister Packets
FDA Statement of Identity
Dietary Supplement
Formula re: Contains
SAMe 200 is a high-quality, stabilized SAMe manufactured under low temperature and low humidity conditions. Each tablet contains a full 200 mg of elemental SAMe from 400 mg SAMe tosylate disulfate.
Formulation re: Other
These enteric extended release tablets offer improved delivery and comply with or exceed the standards for slow-release disintegration and extended release dissolution. Slow-release coating technology optimizes stability in the stomach and enhances direct release and absorption in the small intestine.
Formula re: Contains
SAMe (S-adenosylmethionine) is a derivative of the essential amino acid L-methionine and is formed by combining ATP with L-Methionine. SAMe is a chiral molecule and consists of two stereoisomers: (S,S) and (R,S). This SAMe has a high level (65%) of the (S,S) isomer, the biologically active form.
Formulation re: Other
SAMe has a long history of clinical use with proven benefits for brain metabolism, joint function, and liver detoxification. Some of the reported beneficial actions of SAMe include: Joint and Connective Tissue Strength SAMe supports production of healthy connective tissue and joint structures by contributing its sulfur component for transulfuration processes that help form glucosamine and chondroitin sulfates, critical components of connective tissues. Brain Metabolism SAMe serves as a major source of methyl groups used by the brain in the synthesis of neurotransmitters such as serotonin, L-dopa, dopamine, and related hormones involved in mood regulation. Liver Function Metabolism of SAMe supports synthesis of glutatione and glutathione-dependant enzymes (glutathione peroxidase and glutathione-S-transferase), which are important antioxidants used in liver detoxification processes.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Formulation re: Does NOT Contain
Free of the following common allergens: milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat, gluten, and soybeans.
Suggested/Recommended/Usage/Directions
Suggested Use: Adults: 1 tablet, 2 to 6 times daily or as directed by a healthcare professional. Do not chew or crush tablets.
Formulation re: Other
SAMe 200 is provided in individual foil blister packets to maximize product stability.
Precautions re: All Other
Do not use if outer seal of blister pack is broken.
Storage
Store in a cool, dry place (59 Degrees F - 85 Degrees F) away from direct light.
Formulation re: Other
Produced in compliance with Good Manufacturing Practices (GMPs) and third-party quality certifications.
Precautions re: Children
Caution: If under 18 years of age, pregnant/nursing, have a medical condition or taking a prescription medication - including those related to mood modulation - consult your physician before use. Keep out of reach of children.
Precautions re: Pregnant or Nursing or Prescription Medications
Caution: If under 18 years of age, pregnant/nursing, have a medical condition or taking a prescription medication - including those related to mood modulation - consult your physician before use.
Precautions re: All Other
Do not exceed 1,600 mg SAMe per day (8 tablets). Do not take at night since product may cause anxiety, restlessness and insomnia.
General Statements: All Other Content
SFI
Supplement Facts Panel
* Percent Daily Values are based on a 2,000 calorie diet.
† Daily Value not established.